LCDX (Caliber Imaging & Diagnostics) Change In Receivables: $-0.06 Mil (TTM As of Mar. 2014)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

What is Caliber Imaging & Diagnostics Change In Receivables?

Caliber Imaging & Diagnostics LCDX +166.67% Change In Receivables is $-0.06 Mil as of Mar. 2014.

Caliber Imaging & Diagnostics's change in receivables for the quarter that ended in Mar. 2014 was $0.11 Mil. It means Caliber Imaging & Diagnostics's Accounts Receivable declined by $0.11 Mil from Dec. 2013 to Mar. 2014 .

Caliber Imaging & Diagnostics's change in receivables for the fiscal year that ended in Dec. 2013 was $0.06 Mil. It means Caliber Imaging & Diagnostics's Accounts Receivable declined by $0.06 Mil from Dec. 2012 to Dec. 2013 .

Caliber Imaging & Diagnostics's Accounts Receivable for the quarter that ended in Mar. 2014 was $0.39 Mil.

Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed. Caliber Imaging & Diagnostics's Days Sales Outstanding for the three months ended in Mar. 2014 was 41.58.

In Ben Graham's calculation of liquidation value, Apple Inc's Accounts Receivable are only considered to be worth 75% of book value. Caliber Imaging & Diagnostics's liquidation value for the three months ended in Mar. 2014 was $-15.37 Mil.

Caliber Imaging & Diagnostics  (OTCPK:LCDX) Change In Receivables Explanation

1. Accounts Receivable are created when a customer has received a product but has not yet paid for that product. Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Caliber Imaging & Diagnostics's Days Sales Outstanding for the quarter that ended in Mar. 2014 is calculated as:

Days Sales Outstanding
=Accounts Receivable/Revenue*Days in Period
=0.391/0.858*91
=41.58

2. In Ben Graham's calculation of liquidation value, Caliber Imaging & Diagnostics's accounts receivable are only considered to be worth 75% of book value:

Caliber Imaging & Diagnostics's liquidation value for the quarter that ended in Mar. 2014 is calculated as:

Liquidation Value
=Cash, Cash Equivalents, Marketable Securities-Total Liabilities+(0.75 * Accounts Receivable)+(0.5 * Total Inventories)
=0.23-16.395+0.75 * 0.391+0.5 * 1.006
=-15.37

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Caliber Imaging & Diagnostics Change In Receivables Related Terms

Caliber Imaging & Diagnostics Change In Receivables Historical Data

* Premium members only.

The historical data trend for Caliber Imaging & Diagnostics's Change In Receivables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Caliber Imaging & Diagnostics Change In Receivables Chart

Caliber Imaging & Diagnostics Annual Data
Trend Dec09 Dec10 Dec11 Dec12 Dec13
Change In Receivables
0.14 -0.23 -0.06 -0.17 0.06

Caliber Imaging & Diagnostics Quarterly Data
Dec09 Mar10 Jun10 Sep10 Dec10 Mar11 Jun11 Sep11 Dec11 Mar12 Jun12 Sep12 Dec12 Mar13 Jun13 Sep13 Dec13 Mar14
Change In Receivables Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.22 0.28 -0.17 -0.28 0.11

Caliber Imaging & Diagnostics Change In Receivables Calculation

Change In Accounts Receivable relative to the previous period. It is any increase or decrease in the cash a company is owed by its customers.

Change In Receivables for the trailing twelve months (TTM) ended in Mar. 2014 adds up the quarterly data reported by the company within the most recent 12 months, which was $-0.06 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Change In Receivables →
What does a Change In Receivables of $-0.06 Mil mean?
Caliber Imaging & Diagnostics (LCDX) has a Change In Receivables of $-0.06 Mil as of Mar. 2014. Change in Receivables is the difference between current-period receivables and past-period receivables. View historical data for Caliber Imaging & Diagnostics and its competitors.
Is Caliber Imaging & Diagnostics' Change In Receivables too high?
Caliber Imaging & Diagnostics' current Change In Receivables is $-0.06 Mil.
How does Caliber Imaging & Diagnostics' Change In Receivables compare to VICA and CRVW?
Caliber Imaging & Diagnostics' Change In Receivables of $-0.06 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Change In Receivables for a Medical Devices & Instruments company?
A good Change In Receivables depends on the Medical Devices & Instruments industry context. However, Change In Receivables should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Change In Receivables mean?
A high Change In Receivables can signal that a stock is expensive relative to its fundamentals. Change in Receivables is the difference between current-period receivables and past-period receivables. View historical data for Caliber Imaging & Diagnostics and its competitors. Caliber Imaging & Diagnostics's current Change In Receivables is $-0.06 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Caliber Imaging & Diagnostics stock overvalued right now?
Caliber Imaging & Diagnostics (LCDX) has a current Change In Receivables of $-0.06 Mil. The current Change In Receivables is $-0.06 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Change In Receivables calculated?
Change In Receivables is calculated from a company's financial statements. For Caliber Imaging & Diagnostics (LCDX), the current Change In Receivables is $-0.06 Mil as of Mar. 2014. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Caliber Imaging & Diagnostics Business Description

Address 50 Methodist Hill Drive, Suite 1000, Rochester, NY, USA, 14623
Caliber Imaging & Diagnostics Inc is a medical device company engaged in developing, manufacturing, marketing & selling point-of-care cellular imaging systems to diagnose skin cancer. It offers clinical imaging and research imaging solutions that shows tissue at the cellular level. Its products portfolio includes; VivaScope; VivaScope 3000, 1500 & 2500; and VivaNet and VivaScan.